Clinical Trials in Illinois

Showing 18641-18660 of 19,692 trials

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

NCT00492284

The objective of this study is to determine if combination therapy (reduced-fluence Visudyne followed by Lucentis \[within 2 hours\] or either of two regimens of reduced-fluence Visudyne followed by Lucentis-Dexamethasone triple therapy \[within 2 hours\]) reduces retreatment rates compared with Lucentis monotherapy while maintaining similar vision outcomes and an acceptable safety profile.

Choroidal NeovascularizationMacular Degeneration

QLT Inc.162 participantsStarted Jul 2007

Mobile, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +23 more locations

COMPLETED116 miles

Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V

NCT01134159

Multicenter, retrospective registry to collect 9-12 month follow-up data to evaluate major adverse cardiac events in patients whom have undergone percutaneous coronary intervention and received either Taxus Liberte or Xience V.

Coronary Artery Disease

Medstar Health Research Institute1,200 participantsStarted Jun 2010

Washington D.C., District of Columbia, United States • Davenport, Iowa, United States • West Des Moines, Iowa, United States +7 more locations

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V

Find Trials by Condition in Illinois

Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2)

Intranasal Civamide for Episodic Cluster Headache

Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial

A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache

A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Discharge ALERT: Quality Improvement Initiative

A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder

Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine

Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload

Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer

Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin Sustained Release Versus 3-Day Azithromycin for the Treatment of Strep Throat in Adolescents and Adults

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension

A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment

Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients